Detection of progesterone receptor forms A and B by immunohistochemical analysis

Journal of Clinical Pathology

Volumn 54, Issue 8, 2001, Pages 624-630

  Mote, P A ^a   Johnston, J F ^a   Manninen, T ^b   Tuohimaa, P ^b   Clarke, C L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Immunohistochemistry; Progesterone receptor antibodies; Progesterone receptor isoforms

Indexed keywords

FORMALDEHYDE; PARAFFIN; PEROXIDASE; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CELL STRAIN COS1; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; GENETIC TRANSFECTION; HORMONE DEPENDENCE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE FIXATION;

ANIMALS; ANTIBODIES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COS CELLS; ENDOMETRIUM; FEMALE; FORMALDEHYDE; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; RABBITS; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034881961     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.8.624     Document Type: Article

References (50)

1. 1997 Update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology
2. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women
3. Progesterone receptors and human breast cancer
4. Steroid receptors and other prognostic factors in primary breast cancer
5. Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer
6. Relationship of presence of progesterone receptors to prognosis in early breast cancer
7. Steroid hormone receptors in breast cancer management
8. Endometrial carcinoma
9. Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: High tumor progesterone receptor levels correlate with longer survival
10. The status of receptors in the management of endometrial cancer
11. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium
12. Prognostic significance of hormone receptors in endometrial cancer
13. An exaltation of experts: Concerted efforts in the standardization of immunohistochemistry
14. Immunocytochemistry of hormone receptors in routinely processed tissues
15. Estrogen and progesterone receptors in breast cancer: Comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay
16. Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval
17. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B
18. Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation
19. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function
20. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells
21. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms
22. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform
23. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors
24. The N-terminal region of the chicken progesterone receptor specifies target gene activation
25. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer
26. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism
27. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity
28. Characterization of progesterone receptor A and B expression in human breast cancer
29. Progesterone receptor A and B protein expression in human breast cancer
30. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium
31. Co-localization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle
32. Structure of the human progesterone receptor gene
33. Distribution of progesterone receptor in female mouse tissues
34. Dating the endometrial biopsy
35. Monoclonal antibodies to human progesterone receptor: Characterization by biochemical and immunohistochemical techniques
36. Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies
37. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies
38. Immunohistochemical detection of progesterone receptors in archival breast cancer
39. The N-terminal region of the human progesterone A-receptor
40. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding
41. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody
42. N-Terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors
43. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo
44. Novel monoclonal antibodies against human uterine progesterone receptor. Mapping of receptor immunogenic domains
45. New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry
46. Immunizations
47. Biochemical aspects of aldehyde fixation and a new formaldehyde fixative
48. Fixation for the 1990s: A review of needs and accomplishments
49. Effects of formaldehyde fixation on protein secondary structure: A calorimetric and infrared spectroscopic investigation